{
    "question": "A 45-year-old woman presents to the physician with a history of headache, palpitations, and episodic diaphoresis. She was diagnosed with hypertension in the past and is now regularly taking antihypertensive medication (amlodipine 10 mg once daily). She has had a diffuse thyroid swelling for the past 4 months. She complains of pain in the long bones of her arms and legs for the past 3 months. She is slightly built, appears thin, and is anxious and apprehensive. Her skin is moist and warm. Her weight is 45 kg (99.2 lb) and height is 146 cm (4 ft 7 in); BMI is 21.12 kg/m2. Her pulse is 116/min, the blood pressure is 196/102 mm Hg, the respiratory rate is 29/min, and the temperature is 37.2В°C (99.0В°F). Diffuse and firm thyromegaly is present. Her upper extremities exhibit fine tremors during an anxiety attack. The laboratory test results reveal elevated 24-hour urinary VMA and metanephrines. Serum epinephrine, calcitonin, and parathormone levels are also elevated. Hypercalcemia and hyperglycemia are also noted. What is the most likely diagnosis?",
    "content": {
        "source_1": "This patient's presentation suggests multiple endocrine neoplasia type 2A (MEN 2A). The elevated 24-hour urinary vanillylmandelic acid (VMA) and metanephrines, along with the symptoms of headache, palpitations, and episodic diaphoresis, point to a pheochromocytoma, which is a tumor of the adrenal medulla that secretes catecholamines. Additionally, the patient's hypercalcemia, elevated parathyroid hormone, and bone pain suggest hyperparathyroidism. The diffuse and firm thyromegaly with the patient's symptoms of weight loss, anxiety, and fine tremors suggest medullary thyroid carcinoma, which can secrete calcitonin and cause symptoms similar to hyperthyroidism. MEN 2A is characterized by the combination of pheochromocytomas, medullary thyroid carcinomas, and parathyroid disease. Therefore, given the patient's symptoms and lab findings, MEN 2A is the most likely diagnosis.",
        "source_2": "This patient has symptoms including palpitations, diaphoresis (sweating), and hypertension, along with laboratory findings of elevated urinary VMA (vanillylmandelic acid) and metanephrines, which are suggestive of pheochromocytoma, a tumor of the adrenal gland that overproduces catecholamines (epinephrine and norepinephrine). The patient also has diffuse thyroid swelling with elevated serum calcitonin, suggesting medullary thyroid cancer. Furthermore, the presence of elevated serum parathormone and hypercalcemia suggests hyperparathyroidism. These three conditions together (pheochromocytoma, medullary thyroid cancer, and hyperparathyroidism) are indicative of a condition called Multiple Endocrine Neoplasia type 2 (MEN 2), a rare inherited disorder that leads to the growth of tumors in different endocrine glands. The patient's elevated epinephrine levels and hyperglycemia are also in line with the presence of pheochromocytoma, one of the components of MEN 2.",
        "source_3": "The differential diagnoses for this patient includes: pheochromocytoma, thyroid storm, hyperthyroidism, primary hyperparathyroidism, and multiple endocrine neoplasia (MEN). Pheochromocytoma could explain the hypertension, headaches, palpitations, and diaphoresis due to excessive catecholamine production and release. Thyroid storm and hyperthyroidism could account for her thin appearance, anxiety, thyromegaly, and tremors. However, her symptoms of bone pain and hypercalcemia, along with elevated parathormone levels, suggest primary hyperparathyroidism. But one disease that could explain all these findings is Multiple Endocrine Neoplasia (MEN) type 2. MEN2 is a genetic disorder that leads to the development of multiple tumors in various endocrine glands. In MEN2, there are commonly pheochromocytomas, medullary thyroid carcinomas (which secrete calcitonin), and hyperparathyroidism. This would also explain the elevated 24-hour urinary VMA and metanephrines (pheochromocytoma), calcitonin (medullary thyroid carcinoma), and parathormone levels (hyperparathyroidism). Thus, given her combination of symptoms and lab findings, this patient most likely has MEN2.",
        "source_4": "The prior probability of Multiple endocrine neoplasia type 2 (MEN2) could be quite low in the general population. However, this patient's presentation of headache, palpitations, episodic diaphoresis, hypertension, thyroid swelling, and bone pain is concerning for multiple endocrine pathologies, thereby increasing the probability of MEN2.\n\nMEN2 is characterized by medullary thyroid carcinoma, pheochromocytoma, and primary hyperparathyroidism. The diffuse and firm thyromegaly in this patient could be due to medullary thyroid carcinoma, increasing the posterior probability to around 20%.\n\nThe symptoms of headache, palpitations, and diaphoresis, along with the lab finding of elevated urinary VMA and metanephrines, are suggestive of pheochromocytoma. Pheochromocytoma is a catecholamine-secreting tumor that often causes episodic symptoms, significantly raising the posterior probability to 60%.\n\nThe presence of hypercalcemia along with an elevated parathyroid hormone (PTH) level suggests primary hyperparathyroidism, which raises the posterior probability of MEN2 even further, possibly up to around 90%.\n\nLastly, the elevated calcitonin level is characteristic of medullary thyroid carcinoma, one of the hallmark tumors of MEN2, which would make the posterior probability approach nearly 100%."
    },
    "answer": [
        "Multiple Endocrine Neoplasia type 2A"
    ],
    "accuracy_labels": [
        true,
        false,
        false,
        false
    ]
}